Glaxo Sues Dr. Reddy's Over Generic Imitrex
GlaxoSmithKline PLC sued Dr. Reddy's Laboratories in the U.S. District Court for the Southern District in New York to stop the Indian generics maker from marketing copies of migraine medicine Imitrex...To view the full article, register now.
Already a subscriber? Click here to view full article